Peptides derived from type IV collagen, CXC chemokines, and thrombospondin-1 domain-containing proteins inhibit neovascularization and suppress tumor growth in MDA-MB-231 breast cancer xenografts.
Neoplasia (New York, N.Y.) Dec, 2009 | Pubmed ID: 20019836